KLS Martin and Lithoz Advance 3D Printed Bioceramic Implants

A New Era in Medical 3D Printing: KLS Martin's Milestone Achievement \\[8pt] In a significant move for the medical 3D printing industry, German surgical device manufacturer KLS Martin is on track to deliver its 500th 3D printed bioceramic implant by the end of the third quarter of 2026. This achievement underscores the growing acceptance and integration of 3D printed implants into mainstream medical practices. The implants, made from Lithoz’s calcium phosphate material LithaBone TCP, are now a standard offering on KLS Martin’s IPS Gate platform, a web-based system for planning, ordering, and delivering patient-specific solutions. \\[8pt] ## Advanced Technology for Patient-Specific Solutions \\[8pt] The LithaBone TCP implants are produced using Lithoz’s Lithography-based Ceramic Manufacturing (LCM) 3D printers, which enable the creation of highly customized and porous structures. These structures can be tailored to specific patient needs, allowing for better integration with the body and promoting bone regeneration. The technology also supports fixation methods such as titanium screws or KLS Martin’s SonicWeld Rx system, which uses resorbable polymer pins to create a fully resorbable implant unit, eliminating the need for a second surgery. \\[8pt] ## Implications for ASEAN Factories \\[8pt] For factories in Thailand, Vietnam, Indonesia, and Malaysia, this development opens up new opportunities in the medical manufacturing sector. As 3D printing technology continues to advance, there is a growing demand for high-precision, patient-specific medical devices. Local manufacturers can leverage this trend by investing in 3D printing capabilities and collaborating with medical device companies to produce these innovative implants. This not only enhances their product offerings but also positions them at the forefront of the rapidly evolving medical technology market. \\[8pt] ## Digital Platforms Streamlining Medical Device Delivery \\[8pt] KLS Martin’s IPS Gate platform is a prime example of how digital platforms are transforming the way medical devices are designed, ordered, and delivered. By integrating 3D printing into a seamless digital workflow, the platform enables faster treatment planning and more predictable delivery timelines. This approach is being adopted by other companies as well, such as 3D Systems’ VSP Connect and Insight Surgery’s EmbedMed platform, which both aim to streamline the production and delivery of patient-specific medical devices. \\[8pt] ## Conclusion: Embracing the Future of Medical Manufacturing \\[8pt] The collaboration between KLS Martin and Lithoz highlights the potential of 3D printing in revolutionizing the medical industry. For ASEAN factories, this means an opportunity to diversify their product lines and tap into the growing market for personalized medical devices. By adopting advanced 3D printing technologies and digital platforms, local manufacturers can stay competitive and meet the increasing demand for high-quality, patient-specific medical solutions. \\[8pt]